A Phase 3 Study to Evaluate Petosemtamab Plus Pembrolizumab vs Pembrolizumab in First-line Treatment of Head and Neck Cancer (LiGeR - HN1)
Merus B.V.
Merus B.V.
Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University
Canadian Cancer Trials Group
Mayo Clinic
West China Hospital
Shandong Cancer Hospital and Institute
Brown University
Radboud University Medical Center
Centre Leon Berard
GlaxoSmithKline
University of California, San Francisco
Sunnybrook Health Sciences Centre
UNICANCER
Centre hospitalier de l'Université de Montréal (CHUM)
All India Institute of Medical Sciences, Jodhpur